Prescriptions of risedronate sodium doubled up while alendronate sodium dropped
A research was revealed to study an aspect of prescription changes among bisophosphonate-type single drugs which have led the osteoporosis treatment market.
While a prescription rate of risedronate(original: Actonel), the new bisophosphonate agent, doubled up between 2008 and 2012, the one of al...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
